Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
Roger S McIntyre,1 Henrik Loft,2 Michael Cronquist Christensen3 1Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; 2Department of Biostatistics and Programming, H. Lundbeck A/S, Valby, Denmark; 3Department of Psychiatry Products, H. Lundbe...
Guardado en:
Autores principales: | McIntyre RS, Loft H, Christensen MC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f54be31881b4241a9bec6cb7ab060e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li G, et al.
Publicado: (2016) -
Anhedonia: una revisión conceptual.
por: José María Olivares
Publicado: (1995) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre RS
Publicado: (2017) -
Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Lingfang Yu, et al.
Publicado: (2021) -
Cognitive impairment in depression: recent advances and novel treatments
por: Perini G, et al.
Publicado: (2019)